Arch Oncology Funding: $241M Raised, Series C (2020)
Arch Oncology is based in Brisbane, CA. It has raised $241M in total funding. Latest round: Series C.
Arch Oncology funding overview
Arch Oncology is based in Brisbane, CA. Arch Oncology has raised $241M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2020. The round record for Arch Oncology runs through 2020; nothing later has been disclosed. Investors on record include Eventide Asset Management, Cowen Healthcare Investments, 3x5 Partners, Roche Venture Fund, RiverVest Venture Partners, Lightchain. 6 distinct backers are named across the disclosed rounds.
Arch Oncology has raised $241M in total disclosed funding across the rounds on record.
Who has invested in Arch Oncology?
Eventide Asset Management, Cowen Healthcare Investments, 3x5 Partners, Roche Venture Fund, RiverVest Venture Partners, Lightchain are named among the investors backing Arch Oncology.
What was the latest Arch Oncology funding round?
The most recent disclosed round is a Series C, announced in April 2020.
Where is Arch Oncology based?
Arch Oncology is based in Brisbane, CA.
When did Arch Oncology last raise?
The last disclosed Arch Oncology round closed in April 2020 at Series C.
Every Arch Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Brisbane at a similar stage.
